Moreover, some of the mentioned biochemical markers (like CD40L, NOX2, and 3NT) identified in the mouse models were also step-wise upregulated in CHD patients by the presence of comorbidities such as hypertension or hypertension + diabetes. This evidence concerns the gene CD40LG and hypertensive disorder.